Sanara Medtech
Yahoo Finance • last month
Sanara MedTech Inc. Announces Chief Executive Officer Transition
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SM... Full story
Yahoo Finance • 2 months ago
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to im... Full story
Yahoo Finance • 2 months ago
Sanara MedTech outlines $5.5M–$6.5M THP investment target while advancing surgical segment growth
Earnings Call Insights: Sanara MedTech Inc. (SMTI) Q2 2025 MANAGEMENT VIEW * Ronald T. Nixon, Executive Chairman and CEO, opened the call by highlighting "net revenue of $25.8 million in the second quarter, representing 28% growth year... Full story
Yahoo Finance • 2 months ago
Sanara Medtech earnings beat by $0.26, revenue topped estimates
Investing.com - Sanara Medtech (NASDAQ: SMTI) reported second quarter EPS of $-0.23, $0.26 better than the analyst estimate of $-0.49. Revenue for the quarter came in at $25.83M versus the consensus estimate of $25.15M. Sanara Medtech’s s... Full story
Yahoo Finance • 2 months ago
Earnings call transcript: Sanara MedTech sees revenue surge in Q2 2025
Sanara MedTech Inc. (SMTI) reported a strong second quarter for 2025, with significant growth in revenue and improved net income. The company achieved a net revenue of $25.8 million, reflecting a 28% year-over-year increase, maintaining it... Full story
Yahoo Finance • 2 months ago
Sanara MedTech Inc (NASDAQ:SMTI) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss, Shares Surge 8.4%
Sanara MedTech Inc (NASDAQ:SMTI [https://www.chartmill.com/stock/quote/SMTI]) reported its second-quarter 2025 financial results, revealing a mixed performance relative to analyst expectations. The company’s revenue growth outpaced estimat... Full story
Yahoo Finance • 3 months ago
Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical out... Full story
Yahoo Finance • 3 months ago
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SM... Full story
Yahoo Finance • 6 months ago
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to i... Full story
Yahoo Finance • 7 months ago
Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)
Q4 Net Revenue Increased 49% Year-Over-Year; 2024 Net Revenue Increased 33% Year-Over-Year FORT WORTH, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical t... Full story
Yahoo Finance • 7 months ago
Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
FORT WORTH, TX, March 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical ou... Full story
Yahoo Finance • 9 months ago
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara Med... Full story
Yahoo Finance • 9 months ago
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
OsStic® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara’s existing call points and commercial infrastructure, and complements S... Full story
Yahoo Finance • 9 months ago
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments
Elizabeth Taylor Appointed Chief Financial Officer; Michael McNeil Appointed Chief Accounting Officer and Chief Administrative Officer FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, S... Full story
Yahoo Finance • 9 months ago
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, T... Full story
Yahoo Finance • 2 years ago
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing
FORT WORTH, TX, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and c... Full story
Yahoo Finance • 2 years ago
Sanara MedTech Inc. Announces Third Quarter 2023 Results
FORT WORTH, TX, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and c... Full story
Yahoo Finance • 2 years ago
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates
FORT WORTH, TX, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to im... Full story
Yahoo Finance • 2 years ago
Sanara MedTech to Participate in Two Upcoming Conferences
FORT WORTH, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to i... Full story
Yahoo Finance • 2 years ago
Sanara MedTech Inc. Announces Second Quarter 2023 Results
FORT WORTH, TX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and c... Full story
